PHAR vs REGN: Which Stock is Better?
Side-by-side comparison of Pharming Group NV and Regeneron Pharmaceuticals Inc in 2026
PHAR
Pharming Group NV
—
REGN
Regeneron Pharmaceuticals Inc
$662.88
Key Metrics Comparison
| Metric | PHAR | REGN | Winner |
|---|---|---|---|
| Market Cap | $723.60M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAR
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or REGN a better investment?
Comparing PHAR and REGN: Pharming Group NV has a market cap of $723.60M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and REGN?
PHAR (Pharming Group NV) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAR or REGN?
Both PHAR and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAR or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAR or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $723.60M for PHAR.
Should I buy PHAR or REGN in 2026?
Both PHAR and REGN have investment merit. PHAR trades at $N/A while REGN trades at $662.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and REGN stock?
Key differences: Market Cap ($723.60M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAR or REGN in 2026?
The choice between PHAR and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAR and REGN?
PHAR (Pharming Group NV) has a market cap of $723.60M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.